Drug intelligence / Profile preview

placenta polypeptides

Development stage
Unknown
Lead developer
Japan Bio Products
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Intravenous, Intramuscular
01

Overview

Placenta polypeptides are heterogeneous mixtures of low–molecular weight peptides, amino acids, proteins, lipids, and growth and immune factors enzymatically or hydrolytically extracted from human placenta and formulated as injectable biologic preparations, most widely used in China as placental polypeptide injections. Pharmacological and preclinical studies suggest these extracts provide trophic and immunomodulatory effects, including support of protein synthesis, metabolism, tissue repair, and wound and bone healing, likely via combined actions of bioactive peptides, somatomedin/IGF-like activities, cytokines, and other placental factors rather than a single defined molecular target.[8][9] Clinically, placental polypeptide injections have been used as adjunctive therapy for a range of conditions such as pulmonary tuberculosis, chronic viral hepatitis B and C, and other chronic or debilitating diseases, with large post‑marketing surveillance data in China indicating a low adverse drug reaction rate and generally favorable short‑term safety profile.[5][8][9]

Other names
placental polypeptidesplacental peptide injectionplacenta polypeptide injectionplacental peptide injectionsplacenta polypeptide injections

Beyond the preview

Go deeper on placenta polypeptides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on placenta polypeptides.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call